✦ LIBER ✦

Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies

✍ Scribed by Vito Lorusso; Saverio Cinieri; Marianna Giampaglia; Mariangela Ciccarese; Andrea Tinelli; Vincenzo Chiuri; Corrado Manca; Nicola Silvestris; Giampiero Gasparini; Giuseppe Colucci

Book ID: 113507187
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 136 KB
Volume: 19
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2010.01.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous or Oral Vinorelbine Plus Cap

Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials

✍ Maria Rosa Strada; Raffaella Palumbo; Antonio Bernardo; Alberto Riccardi; Cristi 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 423 KB

Phase II study of oral vinorelbine in co

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

✍ Alison Jones; Mary O’Brien; Harald Sommer; Elzbieta Nowara; Anja Welt; Tadeusz P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 364 KB

421 POSTER A phase I/II study of capecit

421 POSTER A phase I/II study of capecitabine (X) combined with oral vinorelbine (N) as first- or second-line chemotherapy in patients (pts) with locally advanced or metastatic breast cancer (MBC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 505 KB

Letrozole (LE)-Vinorelbine (VIN) as firs

Letrozole (LE)-Vinorelbine (VIN) as first-line treatment in advanced breast cancer (ABC) patients: Preliminary results of a multicentre phase II study

✍ S Barni; P Colina; S Leo; P Sandri; A Savarino; F Pollera; A Ardizzoia; G Barber 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Second-Line Treatment with Intravenous G

Second-Line Treatment with Intravenous Gemcitabine and Oral Etoposide in Platinum-Resistant Advanced Ovarian Cancer Patients: Results of a Phase II Study

✍ Bruzzone, M.; Centurioni, M.G.; Giglione, P.; Gualco, M.; Merlo, D.F.; Miglietta 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 469 KB